PATENT CLAIM ANALYSIS

Application Number: 15769260
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "303000"]

Abstract:
The present invention discloses compounds according to Formula I: wherein R 1 , R 2 , and Cy are as defined herein. The present invention relates to compounds inhibiting IRAK family kinases, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoimmune diseases and/or proliferative diseases by administering the compound of the invention.

Claim (Index 14):
A compound or pharmaceutically acceptable salt thereof, according to any one of  claims 1 - 10 , or a pharmaceutical composition according to any one of  claims 11 - 13  for use in medicine.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15262097', '14599644', '14114218', '14461629', '14441698']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.757350292012906
- 35 USC 102 Novelty (BERT): 0.5127618784940651
- Combined Prediction Score: 0.7328914506610219
- Mean Citation Score: 281.28254
- Max Citation Score: 292.94016
- Similarity Product: 251.4584676741028

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test